BIRMINGHAM, Ala., Sept. 10, 2019 /PRNewswire/ -- Yuva
Biosciences, Inc., an anti-aging company developing
cosmeceuticals as well as pharmaceuticals targeted at
aging-associated hair loss, wrinkled skin, and reduced energy,
today announced that Aubrey de Grey,
Ph.D. and Frank L. Jaksch, Jr. have
joined the Company's Advisory Board.
"We are thrilled to have two of the pioneering thinkers in the
industry, Aubrey de Grey and
Frank Jaksch, join our Advisory
Board," said Greg Schmergel,
Chairman at Yuva Biosciences. "Their expertise will greatly
contribute to the company's development of cutting-edge
mitochondrial science to ease the effects of aging."
Aubrey de Grey, Ph.D., is the
Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) biomedical research
charity that performs and funds laboratory research dedicated to
combating the aging process. He is also Editor-in-Chief of
Rejuvenation Research, a peer-reviewed journal focused on
intervention in aging. He is a highly sought-after speaker who
gives 40-50 invited talks per year at scientific conferences,
universities and companies in areas ranging from pharma to life
insurance, and to the public. He dedicates 30% of his time to AgeX
Therapeutics (ticker symbol: AGE), where he is the Vice President,
New Technology Discovery.
Dr. de Grey commented, "My colleague Dr. Keshav K. Singh, the scientific Founder of Yuva
Biosciences, is a world-class researcher in the field of
mitochondrial science and I am very pleased to see his work now
being turned into products that can help people mitigate aging
related diseases."
Frank L. Jaksch, Jr., the
Co-Founder of ChromaDex, is biochemist with a track record for
successfully licensing and bringing breakthrough science to the
supplements industry. As the first to recognize the commercial
potential of nicotinamide riboside (NR), Mr. Jaksch secured the
exclusive license to bring NR to market through
ChromaDex (NASDAQ: CDXC) where he remains the Executive
Chairman. Mr. Jaksch continues to drive the company's scientific
research strategy with a focus on translating the science into
commercial success.
"I share Dr. Singh's passion for mitochondrial science and its
importance in undoing the effects of aging, and look forward to
helping the company develop the next generation of novel
cosmeceuticals and pharmaceuticals," stated Mr. Jaksch.
About Yuva Biosciences
(www.yuvabio.com)
Yuva Biosciences is an
anti-aging company harnessing the cutting edge of mitochondrial
science to develop cosmeceuticals as well as pharmaceuticals
targeted at aging-related hair loss, wrinkled skin, and reduced
energy. The Company's Scientific Founder and Chief Scientific
Advisor, Keshav K. Singh, Ph.D., is
a world leader in the field of mitochondrial biology and genetics
and its role in health, disease, and aging. Dr. Singh is the Joy
and Bill Harbert Endowed Chair and Director of Cancer Genetics at
the University of Alabama at Birmingham
and the founding editor-in-chief of the Mitochondrion journal
published by Elsevier. Yuva Biosciences is headquartered in
Birmingham, Alabama.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/industry-leaders-aubrey-de-grey-and-frank-jaksch-join-yuva-biosciences-advisory-board-300914080.html
SOURCE Yuva Biosciences, Inc.